U.S. Markets close in 4 hrs 31 mins

CLASS ACTION UPDATE for R, CTMX and ENPH: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

NEW YORK, NY / ACCESSWIRE / July 6, 2020 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.

R Shareholders Click Here: https://www.zlk.com/pslra-1/ryder-system-inc-loss-submission-form?prid=7784&wire=1
CTMX Shareholders Click Here: https://www.zlk.com/pslra-1/cytomx-therapeutics-inc-loss-submission-form?prid=7784&wire=1
ENPH Shareholders Click Here: https://www.zlk.com/pslra-1/enphase-energy-inc-loss-submission-form?prid=7784&wire=1

* ADDITIONAL INFORMATION BELOW *

Ryder System, Inc. (NYSE:R)

R Lawsuit on behalf of: investors who purchased July 23, 2015 - February 13, 2020
Lead Plaintiff Deadline: July 20, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/ryder-system-inc-loss-submission-form?prid=7784&wire=1

According to the filed complaint, during the class period, Ryder System, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) Ryder's financial results were inflated as a result of the Company's practice of overstating the residual values of the vehicles in its fleet; (2) there was no reasonable basis to believe that Ryder would sell its used vehicles for the amounts that it had assigned to them; (3) Ryder's residual values for its fleet of vehicles exceeded the expected future values that would be realized upon the sale of those vehicles; and (4) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

CytomX Therapeutics, Inc. (CTMX)

CTMX Lawsuit on behalf of: investors who purchased May 17, 2018 - May 13, 2020
Lead Plaintiff Deadline: July 20, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/cytomx-therapeutics-inc-loss-submission-form?prid=7784&wire=1

According to the filed complaint, during the class period, CytomX Therapeutics, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) CytomX had downplayed issues with CX-072's efficacy observed in the PROCLAIM-CX-072 clinical program; (ii) CytomX had similarly downplayed issues with CX-2009's efficacy and safety observed in the PROCLAIM-CX-2009 clinical program; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.

Enphase Energy, Inc. (ENPH)

ENPH Lawsuit on behalf of: investors who purchased February 26, 2019 - June 17, 2020
Lead Plaintiff Deadline: August 17, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/enphase-energy-inc-loss-submission-form?prid=7784&wire=1

According to the filed complaint, during the class period, Enphase Energy, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) its revenues, both U.S. and international, were inflated; (2) the Company engaged in improper deferred revenue accounting practices; (3) the Company's reported base points expansion in gross margins were overstated; and (4) as a result of the foregoing, Defendants' public statements were materially false and misleading at all relevant times.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington, D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
http://www.zlk.com

SOURCE: Levi & Korsinsky, LLP



View source version on accesswire.com:
https://www.accesswire.com/596405/CLASS-ACTION-UPDATE-for-R-CTMX-and-ENPH-Levi-Korsinsky-LLP-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders